Peripheral Lung Squamous Carcinoma With ROS1 Rearrangement Sensitive to Crizotinib: A Case Report

ROS1 rearrangements have been identified as driver mutations, accounting for 1–2% of lung adenocarcinoma, but are extremely rare in case of lung squamous cell carcinoma. In this work, we report a lung squamous cell carcinoma in a patient with peripheral lung cancer radiological manifestation, harbor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Guangdie, Wang, Jie, Yao, Yinan, Zhao, Jun, Yu, Zheyan, Gao, Qiqi, Ye, Jiani, Ma, Wenjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256165/
https://www.ncbi.nlm.nih.gov/pubmed/34235088
http://dx.doi.org/10.3389/fonc.2021.703318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256165/
https://www.ncbi.nlm.nih.gov/pubmed/34235088
http://dx.doi.org/10.3389/fonc.2021.703318

Ejemplares similares